Cardiomyopathies
|
0.320 |
GeneticVariation
|
group |
BEFREE |
Increased ANKRD1 levels linked to gain of function mutations have been associated to total anomalous pulmonary venous return and adult cardiomyopathy occurrence in humans.
|
31688894 |
2019 |
Cardiomyopathies
|
0.320 |
Biomarker
|
group |
BEFREE |
Importantly, cardiac ANKRD1 has been shown to be highly induced in various cardiomyopathies and in heart failure, although it is still unclear what impact this may have on the pathophysiology of heart failure.
|
28672880 |
2017 |
Hypertrophic Cardiomyopathy
|
0.320 |
Biomarker
|
disease |
CLINGEN |
Proteomics. Tissue-based map of the human proteome.
|
25613900 |
2015 |
Hypertrophic Cardiomyopathy
|
0.320 |
Biomarker
|
disease |
CLINGEN |
Impact of ANKRD1 mutations associated with hypertrophic cardiomyopathy on contraction parameters of engineered heart tissue.
|
23572067 |
2013 |
Hypertrophic Cardiomyopathy
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
In the present study, we investigated whether expression of HCM-associated ANKRD1 mutations affects contraction parameters after gene transfer in engineered heart tissues (EHTs).
|
23572067 |
2013 |
Hypertrophic Cardiomyopathy
|
0.320 |
Biomarker
|
disease |
BEFREE |
CARP abnormalities may be involved in the pathogenesis of HCM.
|
19608031 |
2009 |
Hypertrophic Cardiomyopathy
|
0.320 |
Biomarker
|
disease |
CLINGEN |
Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy.
|
19608031 |
2009 |
Cardiomyopathies
|
0.320 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Endometriosis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.
|
20864642 |
2011 |
Endometrioma
|
0.300 |
Biomarker
|
disease |
CTD_human |
Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis.
|
20864642 |
2011 |
Familial dilated cardiomyopathy
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy.
|
19525294 |
2009 |
Total Anomalous Pulmonary Venous Return 1
|
0.300 |
GeneticVariation
|
disease |
UNIPROT |
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return.
|
18273862 |
2008 |
Myocardial Reperfusion Injury
|
0.200 |
Biomarker
|
phenotype |
RGD |
Involvement of GADD153 and cardiac ankyrin repeat protein in cardiac ischemia-reperfusion injury.
|
19299913 |
2009 |
Cardiomegaly
|
0.200 |
Biomarker
|
phenotype |
RGD |
Cardiac ankyrin repeat protein is a novel marker of cardiac hypertrophy: role of M-CAT element within the promoter.
|
10904011 |
2000 |
Cardiomyopathy, Dilated
|
0.130 |
Biomarker
|
group |
BEFREE |
MLP and CARP are linked to chronic PKCα signalling in dilated cardiomyopathy.
|
27353086 |
2016 |
Cardiomyopathy, Dilated
|
0.130 |
Biomarker
|
group |
BEFREE |
We evaluated ankyrin repeat domain 1 (ANKRD1), the gene encoding cardiac ankyrin repeat protein (CARP), as a novel candidate gene for dilated cardiomyopathy (DCM) through mutation analysis of a cohort of familial or idiopathic DCM patients, based on the hypothesis that inherited dysfunction of mechanical stretch-based signaling is present in a subset of DCM patients.
|
19608030 |
2009 |
Cardiomyopathy, Dilated
|
0.130 |
GeneticVariation
|
group |
BEFREE |
Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy.
|
19525294 |
2009 |
Cardiomyopathy, Dilated
|
0.130 |
Biomarker
|
group |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Lipodystrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myopathy
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Creatine phosphokinase serum increased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Neutrophil abnormality
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Electromyogram abnormal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Lipoatrophy
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|